Vascular dementia is a common disorder resulting in considerable morbidity and mortality. Determining the extent to which genes play a role in disease susceptibility and their pathophysiological mechanisms could improve our understanding of vascular dementia, leading to a potential translation of this knowledge to clinical practice.
In this review, we discuss what is currently known about the genetics of vascular dementia. The identification of causal genes remains limited to monogenic forms of the disease, with findings for sporadic vascular dementia being less robust. However, progress in genetic research on associated phenotypes, such as cerebral small vessel disease, Alzheimer’s disease, and stroke, have the potential to inform on the genetics of vascular dementia. We conclude by providing an overview of future developments in the field and how such work could impact patients and clinicians.
The genetic background of vascular dementia is well established for monogenic disorders, but remains relatively obscure for the sporadic form. More work is needed for providing robust findings that might eventually lead to clinical translation.
Gorelick PB, et al.; on behalf of the American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.
Pastores GM, Lien Y-HH. Biochemical and molecular genetic basis of Fabry disease. J Am Soc Nephrol. 2002;13:S130–3. PubMed
Clarke JTR. Narrative review: Fabry disease. An Intern Med. 2007;146:425–33. CrossRef
Cordeiro IM, et al. Shifting the CARASIL paradigm report of a non-asian family and literature review. Stroke. 2015;46:1110–2. CrossRef
Dantoine TF, et al. Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. An N Y Acad Sci. 2002;977:239–44. CrossRef
Zuliani G, et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scandin. 2001;103:304–8. CrossRef
Dwyer R, Skrobot OA, Dwyer J, Munafo M, Kehoe PG. Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment. J Alzheimers Dis. 2013;34:145–54. PubMed
Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; Stroke Genetics Network (SiGN); International Stroke Genetics Consortium (ISGC). Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2016;15(7):695–707. CrossRef
NINDS Stroke Genetics Network (SiGN).; International Stroke Genetics Consortium (ISGC). Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol. 2015. http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(15)00338-5/abstract.
Karch CM, Goate AM. Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatr. 2015;77:43–51. CrossRef
Roses AD, et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenom J. 2010;10:375–84. CrossRef
McCarthy AD, Kennedy JL, Middleton LT. Pharmacogenetics in drug development. Philosoph Trans Royal Soc B. 2005;360:1579–88. CrossRef
- Genetics of vascular dementia – review from the ICVD working group
M. Arfan Ikram
Hieab H.H. Adams
- BioMed Central
Neu im Fachgebiet Allgemeinmedizin
Meistgelesene Bücher aus dem Fachgebiet
e.Med Kampagnen-Visual, Mail Icon II